INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,806 | +11.2% | 152 | +43.4% | 0.00% | 0.0% |
| Q2 2023 | $4,323 | +0.9% | 106 | -7.8% | 0.00% | 0.0% |
| Q1 2023 | $4,286 | -30.2% | 115 | -34.7% | 0.00% | 0.0% |
| Q4 2022 | $6,141 | -52.8% | 176 | -22.5% | 0.00% | -66.7% |
| Q3 2022 | $13,000 | +8.3% | 227 | -5.4% | 0.00% | +50.0% |
| Q2 2022 | $12,000 | -33.3% | 240 | -4.4% | 0.00% | -33.3% |
| Q1 2022 | $18,000 | -14.3% | 251 | +38.7% | 0.00% | -25.0% |
| Q4 2021 | $21,000 | -40.0% | 181 | -30.4% | 0.00% | -42.9% |
| Q3 2021 | $35,000 | +25.0% | 260 | +47.7% | 0.01% | +16.7% |
| Q2 2021 | $28,000 | +100.0% | 176 | +2.3% | 0.01% | +100.0% |
| Q1 2021 | $14,000 | -22.2% | 172 | -49.4% | 0.00% | +50.0% |
| Q4 2020 | $18,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |